QPEX BIOPHARMA
Qpex Biopharma develops a pipeline of agents addressing critical needs for the treatment of infectious diseases. It develops multiple antibiotic drugs intended to combat antimicrobial resistance. The company's technology is focused on targeting the treatment of infectious diseases for both inpatient and outpatient cases, deep expertise in the discovery, development and regulatory approval of anti-infective medicines, including an extensive record of working with public/private partnerships focused on new antibiotics to combat antimicrobial resistance, enabling medical businesses optimal use of products and critical needs for the treatment of infectious diseases in the inpatient and outpatient settings. It was founded in 2018 and is headquartered in San Diego, California.
QPEX BIOPHARMA
Industry:
Biotechnology Health Care
Founded:
2018-10-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.qpexbio.com
Total Employee:
11+
Status:
Active
Contact:
858.500.8366
Total Funding:
53 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Domain Not Resolving Euro Microsoft Exchange Online Office 365 Mail
Current Employees Featured
Founder
Investors List
Biomedical Advanced Research and Development Authority (BARDA)
Biomedical Advanced Research and Development Authority (BARDA) investment in Grant - Qpex Biopharma
LYZZ Capital
LYZZ Capital investment in Series A - Qpex Biopharma
Hatteras Venture Partners
Hatteras Venture Partners investment in Series A - Qpex Biopharma
New Enterprise Associates
New Enterprise Associates investment in Series A - Qpex Biopharma
Adams Street Partners
Adams Street Partners investment in Series A - Qpex Biopharma
Stanford University
Stanford University investment in Series A - Qpex Biopharma
Official Site Inspections
http://www.qpexbio.com Semrush global rank: 4.4 M Semrush visits lastest month: 2.54 K
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Qpex Biopharma"
Our Team - Qpex Biopharma
Our team here at Qpex Biopharma. Mr. Griffith brings over 25 years of experience in drug discovery and development and led the teams responsible for non-clinical/clinical pharmacology, toxicology and CMC that supported multiple …See details»
Qpex Biopharma - Crunchbase Company Profile & Funding
Qpex Biopharma develops a pipeline of agents addressing critical needs for the treatment of infectious diseases. It develops multiple antibiotic drugs intended to combat antimicrobial …See details»
Shionogi Further Extends Infectious Disease Innovation Platform …
Jun 26, 2023 “Qpex is thrilled to become part of Shionogi, a world-class organization with an established legacy and commitment to innovation in the development of products for the …See details»
Qpex Biopharma - LinkedIn
Qpex Biopharma, Inc. a Shionogi Group Company, is a resistance-focused infectious disease company on a mission to make both a dramatic and sustainable improvement in patient care.See details»
Shionogi Further Extends Infectious Disease Innovation Platform …
Jun 26, 2023 “Qpex is thrilled to become part of Shionogi, a world-class organization with an established legacy and commitment to innovation in the development of products for the …See details»
News | Qpex Biopharma Initiates Phase 1 Study of QPX9003 …
The company also has a multi-product collaboration with Brii Biosciences for the development and commercialization of three of its products in greater China. For more information, please visit …See details»
Qpex Biopharma Announces Progress on Three Clinical
Jan 19, 2022 For more information, please visit www.qpexbio.com and follow us on Twitter and LinkedIn. Contacts Katherine Carlyle Smith Canale Communications 619-849-5378 …See details»
Qpex Biopharma, a Shionogi Group Company, Receives an …
May 31, 2024 For more information, please visit www.qpexbio.com and follow us on Twitter and LinkedIn. About Qpex and BARDA Partnership Qpex scientists and clinicians have an …See details»
Qpex Company Profile 2024: Valuation, Investors, Acquisition
Qpex General Information Description. Operator of a biopharmaceutical company intended to discover and develop anti-infective therapies. The company is focused on targeting the …See details»
News | Qpex Announces - Qpex Biopharma
Jan 19, 2022 SAN DIEGO, June 17, 2021 – Qpex Biopharma, Inc., (Qpex) a resistance-focused clinical-stage biopharmaceutical company discovering and developing innovative anti-infective …See details»
Qpex Biopharma, a Shionogi Group Company, Receives an …
SAN DIEGO, May 30, 2024--Qpex Biopharma, Inc., a Shionogi Group Company, (hereafter "Qpex") today announced the exercise of a $10 million option from the Biomedical Advanced …See details»
Qpex Biopharma, a Shionogi Group Company, Receives an …
May 30, 2024 Qpex Biopharma, Inc., a Shionogi Group Company, (hereafter “Qpex”) today announced the exercise of a $10 million option from the Biomedical Advanced RSee details»
Qpex Biopharma and Brii Biosciences Enter Into a Strategic ...
Oct 22, 2019 Qpex Biopharma (www.qpexbio.com) is a San Diego-based biopharmaceutical company with a pipeline of best-in-class agents addressing critical needs for treatment of …See details»
Qpex Biopharma | Our Mission
AMR results in a world where the advances in modern medicine are lost When the antibiotics used to rescue vulnerable patients from life-threatening infections can no longer be relied …See details»
Qpex Biopharma Initiates Phase 1 Study of QPX9003 ... - Business …
Jun 17, 2021 For more information, please visit www.qpexbio.com and follow us on Twitter and LinkedIn. Contacts Katherine Carlyle Smith Canale Communications 619-849-5378 …See details»
News | Qpex Announces - Qpex Biopharma
Mar 30, 2022 The company also has a multi-product collaboration with Brii Biosciences for the development and commercialization of three of its products in greater China. For more …See details»
News | Qpex Strengthens Leadership Team and Provides Update …
Jan 5, 2021 Qpex has a multi-product collaboration with Brii Biosciences for the development and commercialization of three of its products in greater China. For more information, please …See details»
Qpex Biopharma Announces Publication of Data in
Mar 30, 2022 For more information, please visit www.qpexbio.com and follow us on Twitter and LinkedIn. Contacts Katherine Carlyle Smith Canale Communications 619-849-5378 …See details»
Qpex Biopharma Announces Presentation of Clinical Data for Ultra …
Apr 21, 2022 For more information, please visit www.qpexbio.com and follow us on Twitter and LinkedIn. Contacts Katherine Carlyle Smith Canale Communications 619-849-5378 …See details»